OncoCyte News and Activities

OncoCyte is owned by Lineage Cell Therapeutics.

Lineage Cell Therapeutics is a company listed under the stock ticker LCTX (US).

View the org chart displaying its 12 main executives

Most searched biographies at OncoCyte

• Joshua Riggs, President and Chief Executive Officer
• Louis Silverman, Director
• Andrew Last, Director

Popular executive movements at OncoCyte

• Steven Tahmooressi has joined the company as Vice President of Marketing  (posted on November 21 2025).

Popular executive movements at Lineage Cell Therapeutics

• Ioana Hone, who was Senior Director, Investor Relations, is promoted to Vice President, Corporate Communications  (posted on April 15 2026).
• Priyantha Herath has joined the company as Senior Vice President, Head of Clinical Operations  (posted on April 15 2026).

Create your alert
to follow the executive moves at OncoCyte.

Lineage Cell Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by OncoCyte

• Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
• Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
• Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
• Oncocyte Reports Third Quarter 2023 Financial Results
• Oncocyte to Announce Third Quarter 2023 Financial Results
• 2023
• Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
• Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
• Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
• Oncocyte Regains Compliance With Nasdaq Listing Requirements
• View more press releases Close

Social media about OncoCyte

• OncoCyte on Wikipedia, Google News & Yahoo Finance
• OncoCyte on LinkedIn, X (Twitter) & YouTube